1281792

Avadel CNS Pharmaceuticals LLC — FEI 3012841301

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 12, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Chesterfield, MO (United States)

Additional Details

Risk Evaluation and Mitigation Strategies (REMS)

Citations

IDCFRDescription
21360FDCA 505-1(f)(4)Failure to comply with REMS Implementation System